Molecular Partners AG (SWX:MOLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
3.080
-0.070 (-2.22%)
May 28, 2026, 5:30 PM CET

Molecular Partners AG Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Molecular Partners AG stock has a consensus rating of "Buy" and an average price target of CHF 9.00. The average 1-year stock price forecast is 192.21% higher than the current stock price, while the lowest is CHF 3.00 (-2.60%) and the highest is CHF 15.00 (+387.01%).

Price Target: CHF 9.00 (+192.21%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
PriceCHF 3.00CHF 9.00CHF 9.00CHF 15.00
Change-2.60%+192.21%+192.21%+387.01%
* Price targets were last updated on Mar 16, 2026.

Analyst Ratings

The average analyst rating for Molecular Partners AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26May '26
Strong Buy111111
Buy000000
Hold111111
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Buy
Maintains
CHF 15.00
BuyMaintainsCHF 15.00+387.01%Mar 16, 2026
J.P. Morgan
J.P. Morgan
Hold
Maintains
CHF 4.00CHF 3.00
HoldMaintainsCHF 4.00CHF 3.00-2.60%Dec 8, 2025
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.